Pet Health

Imha: What to Know and Where to Start

IMHA means immune-mediated hemolytic anemia, a serious condition in which a pet’s immune system destroys its own red blood cells.

Key takeaways

IMHA means immune-mediated hemolytic anemia, a serious condition in which a pet’s immune system destroys its own red blood cells.

  • Immune-mediated hemolytic anemia (IMHA) is a potentially life-threatening blood disorder that affects dogs and cats.
  • Red blood cells carry oxygen throughout the body, so their rapid destruction can leave vital organs and tissues without enough oxygen.
  • The condition can develop suddenly or progress over time.
  • Early veterinary diagnosis and treatment are important because severe anemia and related complications can become emergencies.
  • Although IMHA is more commonly diagnosed in dogs, cats can develop it too.

What IMHA Means and How It Affects Pets

IMHA is an abbreviation for immune-mediated hemolytic anemia.

Each part of the name describes what happens:

• Immune-mediated: The immune system is involved in the destruction of the body's own cells.

• Hemolytic: Red blood cells are broken down or destroyed.

• Anemia: The body has too few healthy red blood cells to carry enough oxygen.

A healthy immune system identifies and attacks harmful organisms while protecting the body's own tissues. With IMHA, this process goes wrong. The immune system produces antibodies that attach to red blood cells, marking them for destruction.

Red blood cells normally transport oxygen from the lungs to the rest of the body. When too many are destroyed, the body cannot deliver oxygen as effectively. The heart and lungs may work harder to compensate, and organs can become affected when oxygen delivery falls.

IMHA can occur in dogs and cats, although it is less common in cats. It may be classified as either primary or secondary.

• Primary IMHA: The immune system attacks red blood cells without an identifiable underlying disease or trigger. This is also called idiopathic IMHA.

• Secondary IMHA: The immune reaction develops in association with another condition, such as an infection, cancer, or certain medication exposures.

Identifying the type helps veterinarians determine whether treatment should address an underlying illness in addition to controlling the immune response.

Why the Immune System Attacks Red Blood Cells

In IMHA, antibodies attach to proteins on the surface of red blood cells.

The immune system then treats those cells as targets and removes or destroys them.

This destruction can happen in different ways:

• Extravascular hemolysis: Immune cells, particularly macrophages in the spleen and liver, remove antibody-coated red blood cells from circulation.

• Intravascular hemolysis: Antibodies activate the complement system, which can damage red blood cells directly inside blood vessels.

Both processes reduce the number of circulating red blood cells. The bone marrow tries to replace the lost cells by producing new ones, but production may not keep pace with destruction.

The underlying reason for this immune reaction varies. Possible contributing conditions include:

• Infections: Certain bacterial, viral, and blood-parasite infections can be associated with immune-mediated red blood cell destruction.

• Cancer: Some tumors and blood cancers can be associated with abnormal immune activity.

• Inflammatory conditions: An ongoing inflammatory disease can contribute to immune system dysfunction.

• Medication reactions: Certain medications can be associated with immune-mediated reactions in susceptible animals.

• Unknown causes: Many pets develop primary IMHA without an identifiable underlying condition.

In cats, veterinarians investigate conditions such as feline leukemia virus (FeLV), feline infectious peritonitis (FIP), and certain blood-parasite infections when evaluating anemia. In dogs, the investigation may include tick-borne infections and other infectious diseases.

Finding an underlying cause helps guide treatment because managing that condition may reduce continued red blood cell destruction.

Signs You May Notice at Home

IMHA can develop rapidly or progress more gradually, depending on how quickly red blood cells are destroyed.

Most noticeable symptoms result from anemia and reduced oxygen delivery to the body's tissues.

Common signs include:

• Lethargy: Sleeping more, moving slowly, or showing less interest in normal activities.

• Weakness: Difficulty walking, reduced stamina, or reluctance to stand.

• Pale gums: Gums may look unusually light pink, white, or nearly colorless.

• Yellow discoloration: The gums, skin, or whites of the eyes may develop a yellow appearance called jaundice.

• Rapid breathing: The pet may breathe faster as the body tries to compensate for reduced oxygen delivery.

• Increased heart rate: The heart works harder to circulate oxygen.

• Reduced appetite: Affected pets may eat less or refuse food.

• Dark urine: Urine may appear reddish, brown, or unusually dark when hemoglobin or other blood breakdown products are present.

• Fever: Some pets develop an elevated body temperature.

• Collapse: Severe anemia can cause profound weakness, fainting, or collapse.

Dogs may also develop an enlarged spleen or a heart murmur during examination. Cats can be particularly difficult to assess because they may hide illness and show only subtle changes in their behavior.

Symptoms do not always appear together. A pet may initially seem tired or less interested in food before developing more obvious signs of anemia.

How Veterinarians Diagnose IMHA

Diagnosing IMHA requires more than finding anemia on a blood test.

The veterinarian needs evidence that red blood cells are being destroyed and that the immune system is involved.

The diagnostic process generally includes the following:

Medical history and physical examination

The veterinarian reviews the pet's symptoms, previous illnesses, medications, vaccination history, travel, and possible exposure to fleas, ticks, or toxins. A physical examination checks gum color, heart rate, breathing, temperature, and signs of jaundice or an enlarged spleen.

Complete blood count

A complete blood count (CBC) measures red blood cells, white blood cells, and platelets. It helps determine the severity of anemia and whether the bone marrow is responding by producing replacement cells.

Blood smear examination

A blood smear allows a laboratory professional to examine red blood cells under a microscope. The examination can reveal abnormal cell shapes, clumping, and other changes associated with hemolysis.

Spherocytes, which are unusually rounded red blood cells, can support an IMHA diagnosis in dogs. This finding is less useful in cats because feline red blood cells have different microscopic characteristics.

Immune-related testing

Veterinarians may use a direct antiglobulin test (DAT), also called a Coombs test, to detect antibodies or complement attached to red blood cells. A saline agglutination test checks whether red blood cells continue to clump when mixed with saline. Flow cytometry is another possible test for identifying immune-related changes on red blood cells.

Additional laboratory tests and imaging

Blood chemistry tests and urinalysis help identify bilirubin, hemoglobin, and signs of organ involvement. Additional infectious disease testing, X-rays, or ultrasound examinations may help identify an underlying infection, toxin exposure, or cancer.

The American College of Veterinary Internal Medicine (ACVIM) recommends combining evidence of anemia, immune-mediated destruction, and hemolysis when establishing a diagnosis. No single test reliably confirms every case, so veterinarians interpret the results together.

Risks, Treatment, and Recovery

IMHA is a serious condition because red blood cell destruction can outpace the body's ability to replace those cells.

Severe anemia can compromise oxygen delivery to vital organs and become fatal.

Blood clot formation is another major concern, particularly in dogs. A clot can travel to the lungs and cause a pulmonary thromboembolism, which can lead to sudden breathing difficulties and other life-threatening complications.

Treatment aims to stop immune-mediated destruction, support oxygen delivery, manage complications, and address any underlying disease.

Immunosuppressive medication

Corticosteroids, such as prednisone or prednisolone, are commonly used to reduce the immune system's attack on red blood cells. These medications help slow the destruction process and give the body time to replace lost cells.

Some dogs need additional immunosuppressive medication when the initial response is inadequate or when treatment-related side effects need to be managed. Medication selection depends on the animal's condition and response.

Blood transfusions

A blood transfusion may be necessary when anemia becomes severe or the pet shows signs of inadequate oxygen delivery. Transfusions provide functioning red blood cells while treatment addresses the underlying immune reaction.

A transfusion does not cure IMHA. It provides temporary support while the veterinary team works to control the disease.

Treatment of underlying conditions

If testing identifies an infection, cancer, or another contributing illness, treatment may also target that condition. Removing or controlling an identifiable trigger can help reduce ongoing red blood cell destruction.

Prevention of blood clots

Veterinarians may prescribe antithrombotic medication to reduce the risk of dangerous clots. Dogs with IMHA require particular attention to this complication, and treatment is selected according to their individual clotting and bleeding risks.

Hospital care and monitoring

Severely affected pets may need hospitalization, intravenous supportive care, oxygen assessment, transfusions, and repeated blood tests. Veterinary teams monitor red blood cell levels, bilirubin, organ function, and treatment response.

Treatment can continue for months, and medication usually requires gradual adjustment as the pet improves. Corticosteroids and other immunosuppressive drugs can cause increased thirst, increased urination, appetite changes, gastrointestinal problems, and greater susceptibility to infections.

Recovery varies with disease severity, underlying causes, complications, and response to treatment. Some pets achieve remission and eventually stop medication, while others experience relapses or need longer-term management.

What to Do if You Suspect IMHA

Suspected IMHA requires prompt veterinary assessment because the condition can worsen quickly.

Owners should take the following steps:

1. Record the symptoms: Note when weakness, appetite changes, pale gums, jaundice, or unusual urine color first appeared.

2. Gather medical information: Prepare a list of current medications, supplements, recent vaccinations, and previous illnesses.

3. Mention possible exposures: Tell the veterinary team about recent travel, tick exposure, medications, and possible contact with toxins.

4. Arrange an examination: The veterinarian can perform blood tests and determine whether emergency stabilization or hospitalization is necessary.

5. Follow the treatment plan: Give prescribed medication as directed and attend scheduled blood tests and follow-up examinations.

If a pet develops collapse, breathing difficulty, or very pale gums, seek emergency veterinary care immediately.

Where to Get Help

A primary care veterinarian is a starting point for evaluating suspected anemia and arranging initial blood tests.

An emergency veterinary hospital is appropriate when symptoms are severe or the pet needs immediate stabilization.

A veterinary internal medicine specialist can provide additional support with complicated or persistent cases. These specialists have experience managing immune-mediated disorders, interpreting specialized blood tests, and coordinating longer-term treatment.

When choosing a veterinary facility, look for access to:

• Complete blood counts and blood smear examinations.

• Specialized testing for immune-mediated red blood cell destruction.

• Blood transfusion services.

• Hospitalization and intensive patient monitoring.

• Veterinary internal medicine consultations.

If the pet has already received an IMHA diagnosis, ask your veterinarian about specialist referral, treatment monitoring, and the expected follow-up schedule.

Frequently asked questions

Is IMHA contagious?

No. IMHA itself is an immune system disorder and cannot spread directly between animals or from pets to people. However, an underlying infectious disease associated with secondary IMHA may have its own transmission risks.

Can vaccinations cause IMHA?

A confirmed causal relationship between vaccination and IMHA has not been established. The ACVIM consensus statement concludes that routine vaccination strategies are generally safe and recommends assessing vaccination benefits and risks individually for each animal.

What does PCV mean in an IMHA blood test?

PCV stands for packed cell volume. It measures the percentage of blood volume made up of red blood cells and helps veterinarians assess the severity of anemia. Repeated PCV measurements can help monitor whether treatment is controlling red blood cell destruction.

What is the difference between a Coombs test and a regular blood count?

A complete blood count measures the number and characteristics of blood cells, including red blood cells. A Coombs test looks for antibodies or complement attached to red blood cells, providing additional evidence of immune involvement. Veterinarians interpret both results alongside other findings when evaluating suspected IMHA.

Editorial standards

Who wrote this guide

Written by VetWayfinder Editorial Team.

Every factual statement is tied to a cited source listed below. Report an error through the corrections page.